Nishi Mirian Y, Domenice Sorahia, Medeiros Maria Aparecida, Mendonca Berenice B, Billerbeck Ana Elisa C
Unidade de Endocrinologia do Desenvolvimento e Laboratório de Hormônios e Genética Molecular Lim/42, Disciplina de Endocrinologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Am J Med Genet. 2002 Feb 1;107(4):299-305. doi: 10.1002/ajmg.10168.
The incidence of Y chromosome sequences in patients with Turner syndrome has been evaluated in several studies, and its frequency varied from 0% to 61%, depending on the molecular methodology used. The aim of our study was to screen for Y chromosome sequences in 122 patients with Turner syndrome without cytogenetic evidence of this chromosome. DNA of 100 normal women was also screened and it was used as a negative control. To identify cryptic Y mosaicism, eight regions of Y chromosome were amplified by PCR. In order to increase the sensitivity of Y sequence detection, a nested PCR of the SRY and TSPY genes was also performed. All patients had several stigmata of Turner syndrome and none of them presented with signs of virilization. The most frequent karyotype was 45,X (54.1%), followed by mosaicism involving structural aberration of the X chromosome. There were 12 patients who carried a marker or ring chromosome. First-round PCR identified Y chromosome sequences in only four patients (3%), and all of them had a chromosome mosaicism with at least one cell lineage with a marker chromosome. After nested PCR, 25% of the patients and 14% of the normal women were positive for the presence of Y sequences. Contamination with extraneous genomic DNA was ruled out by microsatellite studies, but we cannot eliminate the possibility of contamination with PCR products, despite careful handling. We conclude that nested PCR overestimated the frequency of Y sequences in patients with Turner syndrome and should be avoided to prevent false positive results, which lead to unnecessary surgical treatment of these patients.
多项研究评估了特纳综合征患者中Y染色体序列的发生率,其频率在0%至61%之间变化,具体取决于所使用的分子方法。我们研究的目的是对122例无该染色体细胞遗传学证据的特纳综合征患者进行Y染色体序列筛查。还对100名正常女性的DNA进行了筛查,并将其用作阴性对照。为了识别隐匿性Y染色体嵌合体,通过聚合酶链反应(PCR)扩增了Y染色体的八个区域。为了提高Y序列检测的灵敏度,还对SRY和TSPY基因进行了巢式PCR。所有患者都有特纳综合征的几种体征,且均无男性化迹象。最常见的核型是45,X(54.1%),其次是涉及X染色体结构畸变的嵌合体。有12例患者携带标记染色体或环状染色体。第一轮PCR仅在4例患者(3%)中鉴定出Y染色体序列,且所有这些患者都有染色体嵌合体,至少有一个细胞系带有标记染色体。巢式PCR后,25%的患者和14%的正常女性Y序列呈阳性。微卫星研究排除了外源基因组DNA污染,但尽管操作仔细,我们仍无法排除PCR产物污染的可能性。我们得出结论,巢式PCR高估了特纳综合征患者中Y序列的频率,应避免使用,以防止出现假阳性结果,导致对这些患者进行不必要的手术治疗。